Capricor Therapeutics Inc (NASDAQ:CAPR)

4.55
Delayed Data
As of Jun 05
 0.00 / 0.00%
Today’s Change
3.30
Today|||52-Week Range
6.58
+17.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues219.2K414.7K130.5K410.4K
 
 
 
 
 
Depreciation And Amortization41.4K43.3K43.3K43.1K
 
 
 
 
 
 
Operating ExpensesGross Income----87.2K367.2K
 
 
 
General Expenses4.4M3.9M2.8M2.4M
 
 
 
 
 
Research And Development3.1M2.8M1.8M1.6M
 
 
 
 
 
Total Operating Expenses4.4M4.0M2.8M2.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.2M-3.5M-2.7M-2.1M
 
 
 
 
 
Other Expenses7.5K233.4K107.5K-2.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.1M-3.3M-2.5M-2.0M
 
 
 
 
 
Net Income-4.1M-3.3M-2.5M-2.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.1M3.1M3.3M3.5M
 
 
 
 
 
Shares To Calculate EPS Diluted3.1M3.1M3.3M3.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.40-$1.10-$0.80-$0.59
 
 
 
 
 
EPS Diluted-$1.35-$1.05-$0.77-$0.59